EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macrophage Derived Galectin‐3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling

Yibing Chen, Qian Jiang, Xiaowei Xing, Liu Xu, Qijin Zhao, Qidong Zhang, Jingwen Chen, Chunxiao Ma, Xingfeng Liu, Yinfei Lu, Yanjun Wan, Lijuan Kong und 6 weitere

Advanced Science · 2025-09 · 12 (35)

DOI: 10.1002/advs.202504032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.08.2025. Verfasst von Yibing Chen und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and P…. Hauptthemen laut MEDLINE: Galectin 3, Diabetic Nephropathies, Transforming Growth Factor beta1, Macrophages. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences, Chinese Academy of Medical Sciences (CAMS) Central Public-Interest Scientific Institution Basal Research Fund, Beijing Outstanding Young Scientist Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 30% of patients with type 2 diabetes develop diabetic kidney disease (DKD), which has emerged as a major contributor to end stage renal disease. Renal fibrosis represents the final pathological outcome of most chronic kidney disease, particularly DKD. This study demonstrates elevated levels of Galectin‐3 (Gal3), a lectin associated with inflammatory and fibrotic conditions, in the plasma and kidneys of DKD mice. Positive correlations between Gal3 expression and renal fibrosis are observed in both DKD patients and mice. Macrophage‐derived Gal3 is found to promote Transforming growth factor beta 1 (TGFβ1) signaling activation and renal fibrogenesis. Genetic ablation of Gal3 globally or specifically in macrophages, as well as pharmacological inhibition of Gal3, significantly attenuated kidney fibrosis in diabetic mice. Mechanistically, macrophage‐derived Gal3 interacted with TGFβ receptor2 (TGFBR2) and Pro‐TGFβ1, preventing TGFBR2 proteasomal degradation in fibroblasts and increasing TGFβ1 levels in the diabetic kidney. These events enhances TGFβ1 signaling activation and ultimately facilitated kidney fibrosis. The findings of this study suggest Gal3 as a potential therapeutic target for renal fibrosis and DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Galectin 3Diabetic NephropathiesTransforming Growth Factor beta1MacrophagesAnimalsMiceFibrosisSignal TransductionHumansKidneyMaleMice, Inbred C57BLReceptor, Transforming Growth Factor-beta Type IIDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

DKDTGFβ1 signalinggalectin‐3protein degradationrenal fibrosis

Substanzen

Galectin 3Transforming Growth Factor beta1Receptor, Transforming Growth Factor-beta Type II

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, 221004, China.
  • Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100034, China.
  • Internal Medicine/Section of Nephrology, Yale University, New Haven, CT, 06520, US.

ORCID-Profile: Pingping Li

Förderung

  • CAMS Innovation Fund for Medical Sciences
  • Chinese Academy of Medical Sciences (CAMS) Central Public-Interest Scientific Institution Basal Research Fund
  • Beijing Outstanding Young Scientist Program
  • National Key R&D Program of China
  • Special Research Fund for Central Universities, Peking Union Medical College
  • Beijing Natural Science Foundation
  • Science and Technology Commission of Tongzhou District, Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Chen, Y., Jiang, Q., Xing, X., Xu, L., Zhao, Q., Zhang, Q., Chen, J., Ma, C., Liu, X., Lu, Y., Wan, Y., Kong, L., Hou, S., Lu, Q., Cui, B., Guo, J., Huang, H., & Li, P. (2025). Macrophage Derived Galectin‐3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling. Advanced Science, 12(35). https://doi.org/10.1002/advs.202504032

Vancouver

Chen Y, Jiang Q, Xing X, Xu L, Zhao Q, Zhang Q, et al. Macrophage Derived Galectin‐3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling. Advanced Science. 2025;12(35). doi:10.1002/advs.202504032

BibTeX
@article{Chen2025,
  author = {Chen, Yibing and Jiang, Qian and Xing, Xiaowei and Xu, Liu and Zhao, Qijin and Zhang, Qidong and Chen, Jingwen and Ma, Chunxiao and Liu, Xingfeng and Lu, Yinfei and Wan, Yanjun and Kong, Lijuan and Hou, Shaocong and Lu, Qian and Cui, Bing and Guo, Jiankan and Huang, Hongdong and Li, Pingping},
  title = {Macrophage Derived Galectin‐3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {35},
  doi = {10.1002/advs.202504032}
}
Kostenlos starten →